Patrice Lee
Impact in
-
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
-
- Microtubule and mitosis dynamics
Papers in
-
- Melanoma and MAPK Pathways 3
- Protein Degradation and Inhibitors 2
-
- Cancer Mechanisms and Therapy 5
- Co-authors
- Peter de Vries (1 shared paper)Scott Peterson (1 shared paper)Andres Forero‐Torres (1 shared paper)Daniel Watson (1 shared paper)Anita Kulukian (1 shared paper)Robert Rosler (1 shared paper)James D. Winkler (5 shared papers)Christine Lemieux (4 shared papers)
- Journals
- Cancer Research (5 papers)Blood (4 papers)Journal of Medicinal Chemistry (2 papers)Bone (1 paper)Current Opinion in Critical Care (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Patrice Lee
17 papers receiving 426 citations
Peers
Comparison fields: 5 of 66
- Oncology 164
- Cell Biology 57
- Genetics 28
- Molecular Biology 157
- Radiology, Nuclear Medicine and Imaging 48
Countries citing papers authored by Patrice Lee
This map shows the geographic impact of Patrice Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Lee more than expected).
Fields of papers citing papers by Patrice Lee
This network shows the impact of papers produced by Patrice Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Lee. The network helps show where Patrice Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrice Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 154 | |
| 2 | 2010 | 55 | |
| 3 | ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. | 2009 | 51 |
| 4 | 2018 | 37 | |
| 5 | 2005 | 34 | |
| 6 | 2018 | 33 | |
| 7 | 2007 | 20 | |
| 8 | Abstract #1795: In Vitro and in vivo activity of ARRY-380: A potent, small molecule inhibitor of ErbB2. | 2009 | 20 |
| 9 | ARRY-520, a KSP inhibitor with efficacy and pharmacodynamic activity in animal models of solid tumors | 2007 | 9 |
| 10 | 2021 | 4 | |
| 11 | 2000 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2015 | 2 | |
| 14 | 2015 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2012 | 1 | |
| 17 | 2008 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2006 | 0 | |
| 20 | Differential activity of ARRY-543, a potent, small molecule inhibitor of EGFR/ErbB-2 compared to lapatanib in in vivo xenograft models | 2008 | 0 |
About Patrice Lee
Patrice Lee is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Organic Chemistry and Immunology, having authored 20 papers that have together received 432 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), HER2/EGFR in Cancer Research (3 papers), Melanoma and MAPK Pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Microtubule and mitosis dynamics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Synthesis and biological activity (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (164 citations), Cell Biology (57 citations), Genetics (28 citations), Molecular Biology (157 citations) and Radiology, Nuclear Medicine and Imaging (48 citations). Patrice Lee has collaborated with scholars based in United States and Italy. Frequent co-authors include Peter de Vries, Scott Peterson, Andres Forero‐Torres, Daniel Watson, Anita Kulukian, Robert Rosler, James D. Winkler, Christine Lemieux, Karyn Bouhana and Richard Woessner. Their work appears in journals such as Cancer Research, Blood, Journal of Medicinal Chemistry, Bone and Current Opinion in Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.